Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...
Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback